Let me know when the data is updated again

CHAVEZ ORTIZ RAFAEL

Summary of sales of medicines and medical supplies

593 purchase as supplier for a total of 3.2 millones (3,187,898.39 ) between 2009 and 2017.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

1.9 millones pesos mexicanos (1,943,325.378 MXN)

Overcost in %

310.1 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
GABAPENTINA 32 97,481 MXN 56,868.3 MXN 236.8 % 2010 - 2014
SERTRALINA 23 154,278 MXN 129,081.4 MXN 519.7 % 2013 - 2015
INSULINA LISPRO LISPRO PROTAMINA 20 176,772 MXN 61,905.2 MXN 47.4 % 2010 - 2014
ATORVASTATINA 19 69,888 MXN 49,768.5 MXN 212.7 % 2010 - 2012
BROMURO DE TIOTROPIO 17 13,955 MXN 6,326 MXN 81.9 % 2010 - 2010
INDOMETACINA 15 41,781 MXN 33,200.9 MXN 399.8 % 2010 - 2016
OXCARBAZEPINA 13 55,790 MXN 15,568.5 MXN 144.7 % 2010 - 2012
TRAMADOL-PARACETAMOL 10 100,543 MXN 71,877.1 MXN 280.4 % 2013 - 2016
AMLODIPINO 9 94,709 MXN 76,035.9 MXN 448.8 % 2013 - 2016

Location

Country

México

GENERAL INFORMATION

Identifiers

RFC: CAOR560818M46

Source(s)

comprasimss

Part of the project

Salud, Dinero y Corrupción

Organization responsible for the import

PODER